Arizona State University COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020 The pace of development for CRISPR-based infectious disease assays increased as the pandemic progress Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients. ASU Team Wins $6M in Government Funding to Develop Rapid Saliva Testing System for Coronavirus The test will be designed to run on a portable device that can ultimately be rolled out to point-of-need settings such as doctors' offices and workplaces. Takara Bio, BioSyntagma Develop High-Throughput SARS-CoV-2 Detection Method The new method uses Takara Bio's SmartChip PCR instrument, chips, and reagents to run 5,184 reactions per chip in less than 30 minutes. New Method for Detecting Point Mutations Could Significantly Impact Low-Cost Diagnostics Premium The method can be used with isothermal amplification and paper-based readouts to detect infectious disease drug resistance in low-resource areas. Aug 29, 2019 Baylor, Arizona State University Nab $1.6M NIH Grant to Develop Genome Editing Governance Jul 24, 2019 DARPA Awards ASU $38.8M to Build Epigenetic-Based Device to Measure WMD Exposure Jun 5, 2019 Complex Human Movements in Siberia, American Arctic Traced by Ancient DNA Studies Dec 4, 2018 Q&A: Gary Marchant Discusses Research on Genetic Testing Lawsuits, Future Liability Premium Jun 21, 2018 Systems Biology Study of Alzheimer's Disease Supports Ties to Virus Jan 15, 2018 BARDA-Funded Radiation Exposure MDx Test Development Continues Apace Premium Nov 16, 2017 CRISPR Patents Must Be 'Reined In,' Experts Say May 31, 2017 Desert Tortoise Genome Gives Glimpse of Adaptation to Arid Climate, Longevity Mar 7, 2017 Exosome Surface Markers May Enable Cancer-Specific Dx Tests Premium Feb 9, 2017 Nanoparticle Method Offers Potential for Simple, Point-of-Care Exosome-Based Diagnostics Premium Oct 6, 2016 NHGRI Awards $6.8M in Grants for DNA, RNA Sequencing Technology Development May 6, 2016 New Zika Test Uses Isothermal RNA Amplification for Detection, CRISPR/Cas9 for Strain ID Premium Apr 26, 2016 HPV Antibodies May Become Cancer Biomarkers With New Protein Array Technology Premium Dec 31, 2015 Sequencing Study Points to Malaria Parasite Diversity in Colombia Aug 20, 2014 Ancient Peruvian Samples Point to TB Transfer to New World via Marine Mammals Dec 12, 2013 ASU Lab Develops Emulsion-based Continuous Flow Droplet qPCR for the Deep Sea and Beyond Premium Sep 23, 2013 Mayo Clinic, Collaborators Establish Arizona Biobank Aug 6, 2013 Moore Foundation Awards ASU Researchers $1.8M to Develop Microscopy Technology Jul 9, 2013 IP Roundup: Panasonic, Ambergen, Illumina, Corning, Seng Enterprises, Charm Sciences, and More Premium Jun 27, 2013 Genomics in the Journals: 2013.06.27 Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.